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1. Cardiovascular Disease Statistics  
Blood pressure regulation is essential in the maintenance of bodily health. A well-
regulated blood pressure can correlate towards a longer and healthier life, especially by 
the avoidance of cardiovascular disease (Egan et al, 1989). This is a very important task 
our bodies take on every day. According to the Center for Disease Control and 
Prevention, cardiovascular disease is the leading cause of death for people of most racial 
and ethnic groups in the United States. Approximately 1 in 4 American deaths, nearly 
655,000 people, are the result of cardiovascular disease (Murphy et al, 2017). This can be 
attributed to millions of people being affected by blood pressure dysregulation, most 
typically hypertension, which can then lead to stroke, heart attack, and renal failure 
(Chobanian et al, 2003). A more recent study showed that high body mass index, high 
blood glucose levels, and smoking also greatly increased the risk of cardiovascular 
disease and contribute to poor blood pressure regulation, as well as being the biggest 
contributing factor in years of life lost (American Heart Association News, 2016). 
Overall, within the United States alone, the cost of heart disease was $219 billion each 
year from 2015 (Virani et al., 2021). Poor blood pressure regulation contributes to build-
up of plaques that restrict blood flow causing ischemia and potential infarction, or the 
weakening and stiffening of arteries promoting increased risk of stroke, arterial 
dissection, and aneurysms, and other target organ damage (e.g., renal failure). As a result, 




Poor regulation of blood pressure due to genetics, lack of exercise, and poor diet 
can be a large contributing factor in the cardiovascular disease process, whether it be 
arteriosclerosis, atherosclerosis, coronary artery disease, etc. While we can somewhat 
prevent and treat a few of these diseases medically, these interventions can be invasive, 
costly, and if treatment is not sought, debilitating. Below is a figure provided by the 
American Heart Association regarding leading causes of death in 2015 (American Heart 
Association News, 2016). Heart disease continues to be detrimental to the lives of 
Americans. With 23.4% of total causes of death being contributed to heart disease, there 
remains a need to promote better ways of living, gain better access to medical care, and 




Blood pressure generally responds by counteracting the therapies used to correct 
blood pressure. For example, administration of vasodilators causes a reduction in blood 
pressure, but the body attempts to correct this by increasing heart rate and thus 
maintaining previous cardiac output. With mechanisms such as this being impaired, the 
dysregulation then causes further cardiovascular disease by overworking the heart and 
overstretching the vasculature. Certain areas regarding the mechanisms of blood pressure 
control are not entirely known. It is the goal of this study to develop a better 
understanding of cardiovascular function regarding blood pressure control.  
 
2. Blood Pressure Control 
Blood pressure control is an essential part of everyday life because blood pressure 
is constantly changing based on activity level, level of arousal, or even our circadian 
rhythms. Blood pressure in the aorta and large arteries acts as the driving force to move 
arterial oxygenated blood through the tissues.  There are multiple mechanisms geared 
toward controlling blood pressure to meet physiological and pathophysiological 
challenges to the body. For example, our bodies control blood pressure and heart rate as a 
means to deliver oxygenated red blood cells to places that need oxygen.  Thus, our blood 
pressure and heart rate increase with exercise, as one means by which to supply extra 
blood flow to the muscles that are using so much oxygen. When this does not occur, the 
lack of the oxygen causes the burning pain associated with anaerobic metabolism and 
lactic acid production. The key aspect to is that in addition to triggering pain, the lactic 
acid or other metabolites built up in the exercising muscle trigger a neural response 
(chemoreflex response) to activate the sympathetic nervous system and increase blood 
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pressure. This, in turn, helps force more blood to the exercising muscle. This is an 
example of chemoreflex control of blood pressure with which most are familiar. 
With blood pressure varying throughout the day, our bodies must regulate it to 
prevent possible cardiovascular injury. For short periods, this elevated blood pressure and 
heart rate is beneficial to the overall cardiovascular health, but long periods of this high 
blood pressure and heart rate can put added stress to vital organs, such as the heart and 
kidneys. Activation of mechanisms such as chemoreflexes may help respond to 
challenges, but they also cause blood pressure excursions. Moreover, continued 
unregulated blood pressure excursions can lead to changes in the vasculature, kidney and 
other organ that can promote cardiovascular disease (Stevens, 2016). Therefore, it is 
essential to have mechanisms to regulate BP with an acceptable range despite variations 
in daily activities or other challenges such as stress. A good deal of evidence shows that 
the arterial baroreflex is on such mechanism by constantly monitoring and adjusting 
blood pressure according to bodily needs.  
The baroreflex controls blood pressure by sensing small changes in pressure. 
These baroreceptors mainly lie within the aortic arch and in the carotid sinus, being a key 
part of influencing blood pressure. This sends afferents signals to the brain, which in turn, 
modifies the sympathetic nervous system. This baroreflex also regulates vasopressin, also 
known as anti-diuretic hormone (ADH), release from the pituitary gland, thus regulating 
increased intravascular volume (Sved et al, 2009). 
These small changes in pressure causes a certain amount of stretch to occur on the 
blood vessels. Diseases can alter this stretch, and therefore altering the baroreceptor input 
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and the negative feedback loop involved. The baroreflex input controls many facets of 
homeostasis through the central nervous system, such as arterial blood pressure, vascular 
resistance, heart rate, and heart contractility. This is a negative feedback system so that an 
increase in BP causes a decrease in sympathetic function. However, there are other less 
well understood mechanisms to regulate blood pressure and cardiovascular function. 
With this understanding, learning about the hidden mechanisms behind blood pressure 
regulation and how these mechanisms can be manipulated can be a potential way in 
leading longer, healthier, and more productive lives. 
Figure 2. Changes in baroreceptor afferent activity reflexively influence many outputs of 
the brain relevant to cardiovascular regulation (adapted from Sved et al, 2009) 
 
The kidneys are an important factor in regulating blood pressure, as nearly 20 to 
25% of cardiac output goes to the kidneys for filtration of wastes and management of 
electrolytes, but we will be focusing on the heart and its regulation of blood pressure. The 
kidney relates to our own project by how sympathetic afferents go from the kidney to the 
brain affect blood pressure. In our case, however, we will be looking more into cardiac 
afferents instead of renal afferents. Renal afferents do however enable us to understand 
some mechanisms of blood pressure due to both of them involving sympathetic stimuli. 
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These renal afferents project to the paraventricular nucleus as well. These afferents cause 
a similar increase in blood pressure and heart rate (Veiga, 2021). 
In addition to the baroreflex, there are other less well understood reflex 
mechanisms to regulate blood pressure and cardiovascular function. Expanding our 
knowledge of these mechanisms and how they may be manipulated can be a potential 
way to understand cardiovascular disease, and develop therapies leading to longer, 
healthier, and more productive lives. It is the goal of this study to develop a better 
understanding of one such mechanism that impacts blood pressure regulation, the cardiac 
sympathetic afferent reflex.  
 
Figure 3.  This flow chart provides an example of how the baroreflex responds to 
a change in sympathetic tone to increase blood pressure and heart rate to meet oxygen 




3. Cardiac Sympathetic Afferent Reflex (CSAR) 
The CSAR, in general terms, sends a nerve impulse from the heart to the brain for 
interpretation and response. This reflex has been shown to be stimulated by capsaicin and 
bradykinin when applied to the left ventricle. Upon this stimulation, blood pressure and 
heart rate seem to be changed dramatically over the next 5-15 minutes. This stimulation, 
which seems sympathetic in nature due to the increase in blood pressure and heart rate, 
could be an important factor in integrated mechanisms of blood pressure control. 
Sympathetic responses, as mentioned earlier, are the basic flight-or-flight response when 
we sense impending danger. These responses have caused people to survive much longer 
after certain circumstances by shunting blood to essential areas of the body. 
Understanding what brings about CSAR activity and its effects on blood pressure control 
is important to understanding the further evolvements in hypertension and other 
cardiovascular processes. It is said that an enhanced CSAR is partially responsible for the 
pathogenesis of cardiovascular disease. Thus, blockade of this CSAR shows beneficial 
effects in chronic heart failure and hypertension (Chen et al., 2015).   
Looking deeper into the pathophysiology of the heart and its possible relations to 
the CSAR reflex, we then can understand these mechanisms and how to treat certain 
cardiovascular diseases. Chronic heart failure is a big factor in years of life lost due to 
progression of other risk factors such as hypertension, coronary artery disease, valvular 
dysfunction, and cardiomyopathy. Right-sided heart failure is associated with fluid 
retention in the abdomen, feet, and hands. Left-sided heart failure is associated with 
pulmonary hypertension, fluid in the lungs, and shortness of breath. Heart failure is 
characterized by an elevation of sympathetic tone. A study on sham dogs and dogs with 
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pacer-induced heart failure found that sympathetic activity was increased in heart failure 
and that sympathetic afferents are sensitized as well (Wang & Ma, 2000). In this study, 
they concluded that an understanding of neural regulation of blood pressure in regard to 
the sympathetic system may be a target for therapies for chronic heart failure, as well as 
other cardiovascular diseases. Another study on chronic heart failure arrived at the same 
conclusion. However, this study included epicardial lidocaine treatment which inhibited 
the CSAR reflex, and therefore, decreased sympathetic activity in the chronic heart 
failure rats and had no effect in sham rats. This piece of work suggested that there is an 
imbalance between cardiac and peripheral responses to CSAR in chronic heart failure and 
sham rats (Wang, Rozanski, & Zucker, 2017) . Other findings showed that, with the 
elevated CSAR activity in CHF animals, other afferent reflex facets could see the same 
type of response and could induce further disease states with prolongation (Adam et al, 
2019). This means that with CHF there is increased cardiac afferent activation, other 
sympathetic afferents caused further stress to the cardiovascular system. They looked into 
TRPA1 channel agonists and the difference in CSAR/PSAR stimulation in sham and 
CHF rats. They found that the CHF rats had an increased effect compared to the sham 
rats, such as the other studies above (Adam et al, 2019).  
From increased inotropic and dromotropic effects to the stiffening and narrowing 
of arteries in atherosclerosis, there are many different factors that can both increase and 
decrease blood pressure. Over time, our body resets itself when facing chronic hypo- and 
hypertension. Chronic hypertension is associated with a lower life expectancy due to 
stroke, renal failure, etc. Optimal blood pressure is 120 mmHg systolic and 80 mmHg 
diastolic. Small deviations from this normal has little-to-no effect on the individual. Big 
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changes can be detrimental to the individual’s health. Mean arterial pressure (MAP) with 
this normal blood pressure lies at around 93 mmHg. With severe hypotensive states, a 
MAP of 65 mmHg and lower is not enough to perfuse the brain and other vital organs 
and must be corrected immediately. Hypertension is often defined as a systolic blood 
pressure above 140 mmHg and a critically dangerous high blood pressure is usually 
around 180 mmHg and above, but can often reach into the low 200s. While we often use 
Beta-1 antagonists, such as Metoprolol, and Beta/Alpha antagonists, such as Labetalol, to 
prevent and manage this condition, it remains important to control this essential 
hypertension from its mechanism, other than treating the effects of this mechanism. We 
know that the kidneys, heart, vasculature, central nervous system, and immune system are 
the main neuroendocrine systems involved with the regulation of blood pressure and 
management of perfusion (Oparil et al, 2018). As for hypertension, an increase in 
sympathetic tone results in an increase in blood pressure. 
 
Figure 4. This figure represents a how a CSAR response is triggered and the expected 
effects of a CSAR response. 
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Many other studies have shown that essential hypertension is accompanied by 
sympathetic activation. Secondary hypertension, like that associated with disease 
processes such as chronic kidney disease, showed sympathetic activation similar to that 
of normotensive, non-diseased subjects (Rahn, Barenbrock, & Hausberg, 1999). Similar 
findings have been found in other studies including dogs and dogs with pacing-induced 
chronic heart failure. They found that the CSAR is augmented in heart failure and that 
regulation of sympathetic outflow is likely mediated by peripheral inputs modulated by 
central substances (Wang & Ma, 2000). Figure 5 is a diagram showing pathogenesis of 
cardiovascular disease and acute stressors (Rozanski, Blumenthal, & Kaplan, 1999). 
 
Figure 5. The figure above shows how an acute stressor contributing to the sympathetic 





4. Sex Differences in Blood Pressure Control 
Blood pressure regulation can also vary by sex. Statistically, men are more likely 
to suffer from a cardiovascular event than women (Ghosh, Mukhopadhyay, & Barik, 
2016). Males and females differ on many different levels. For one, the female must have 
the ability to accommodate for a developing fetus and be able to sustain a pregnancy. 
This, by itself, is a large feat. The female body will change greatly during gestation. For 
example, during human gestation, there is an increase in cardiac output, expanded blood 
volume, reduced systemic vascular resistance and blood pressure. Additionally, while 
females are somewhat protected from cardiovascular events before menopause, but the 
risk greatly increases after menopause. Thus, it is clear that sex differences exist for a 
number of cardiovascular functions. 
From this evidence, we can see that sex hormones do play a part in blood pressure 
control. Other work examined sex hormones and age in relation to blood pressure control. 
Their study looked deeper into the differences in sex hormone production in males, 
premenopausal females, and postmenopausal females in regard to blood pressure control 
and cardiovascular function. They found that while females exhibited decreased 
prevalence in hypertension than males, postmenopausal women did have higher 
incidences of hypertension than premenopausal women. Older men and younger men did 
not have this same relationship. This was proposed to be estrogen working against 
adrenergic alpha receptor mediated constriction of the vasculature, meaning that estrogen 
exhibited an offsetting effect working against the alpha-1 receptors (Baker et al, 2016). 
Alpha-1 receptors are influential in the constriction of peripheral vasculature, therefore 
increasing vascular resistance and increasing blood pressure. The main difference in the 
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groups studied above is their neuroendocrine production and secretion of sex hormones. 
Men generally have the same amount of circulating testosterone from puberty to death, 
with small gradual decreases from age 35 and on. Women, however, are quite different. 
From menarche to the start of menopause, estrogen and progesterone levels increase and 
decrease alongside the menstrual cycle intervals, with peaks being during pregnancy. 
Once menopause starts, estrogen levels decrease significantly. This coincides well with 
the previous study mentioned, as sex hormones do potentially play a large role in 
autonomic neural function. 
With men being more likely to have a cardiac event, we must dive into why there 
is this difference in sex. One school of thought is the androgens exert a harmful effect on 
the cardiovascular system. This has been studied in mammalian species and the influence 
of androgens on oxidative stress. It has been shown that males have an increased amount 
of reactive oxygen species. Similar studies have been on female mammals with 
ovariectomies being treated with testosterone. The studies mentioned above include the 
possibility of the oxidative stress releasing vasoconstrictor substances or impairing 
vasodilator mechanisms (Reckelhoff, 2001). Studies have also been completed on men 
versus premenopausal women vs postmenopausal women. Premenopausal women were 
shown to have reduced risk of cardiovascular disease compared to men of all ages, but 
postmenopausal women were shown to have similar, if not greater risk (Maranon and 
Reckelhoff, 2013) (Ramirez & Sullivan, 2018). This brings to question the role of 
estrogen’s involvement and influence on blood pressure. One study showed that female 
sex hormones, especially estrogen, have linkages to the renin-aldosterone-angiotensin 
(RAA) system. This study also showed that estrogen has beneficial effects on not only 
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the heart and kidneys, but the vasculature and central nervous system as well. On a neural 
and central nervous system level, they investigated the central regulatory actions of 
estrogen on brain nuclei involved in blood pressure and heart rate control. This showed 
that estrogen plays a protective role against hypertension, especially since hypertension in 
pregnancy can be dangerous due to conditions such as eclampsia (Xue, Johnson, & Hay, 
2013). A Barnes’ study in 2017 compared older women, younger women, and men of all 
ages. This study found that, while postmenopausal women and adult men have similar 
systolic, diastolic, and mean blood pressures, they are much higher in comparison to 
younger women. The authors suggest there are many clinical applications of focusing on 
autonomic control of the circulation, specifically around the basis of age and sex, 
alongside an endocrinologic approach (Barnes, 2017). Another study in 2016 focused on 
muscle sympathetic nerve activity (MSNA), which showed that there is a strong and 
complex link between sex and age in regard to cardiovascular function. The study also 
looked deeper into the beta- and alpha-adrenoreceptor mediated vascular effects. Alpha 
being the peripheral vasculature control of blood pressure (via norepinephrine) and beta 
being the central control with inputs on cardiac output by affecting both heart rate and 
stroke volume (Limberg et al, 2016). Beta-agonists work on beta receptors that can be 
found in the heart (Beta-1), as well as the lungs and skeletal muscle blood vessels (Beta-
2). Beta-1 agonists act to increase inotropy, chronotropy, and dromotropy of the heart. 
Beta-2 agonists work to cause bronchodilation, enabling more oxygen delivery to the 
alveoli and thus the bloodstream. Beta-2 agonists also work in dilation of skeletal muscle 
blood vessels to increase oxygen supply. Working together, this causes more oxygen to 
be delivered to the tissues requiring it. 
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This determination of if androgens influence a higher occurrence of hypertension 
or estrogen inhibits this response will be able to direct future studies on sex hormones 
and blood pressure control. With the elevated estrogen levels in young females possibly 
affecting blood pressure more so than males and older females, another potential area of 
interest would be estrogen levels in pregnancy and maternal blood pressure. As we know, 
estrogen levels greatly increase in pregnancy and while blood volume in pregnancy 
increases, the overall blood pressure generally decreases. High maternal blood pressure is 
associated with a higher risk of eclampsia, post-partum hemorrhage, and potential fetal 
harm. Figure 6 is based off a study regarding sex hormones on sympathetic activation 
(Ghosh, Mukhopadhyay, & Barik, 2016).  
 
Figure 6. Activation of the sympathetic nervous system causes a cascade of events to 
occur with the end result being increased blood pressure and heart rate until the 





5. Estrous Cycle in Rats 
With our focus being on sex differences in blood pressure regulation a natural 
consideration is an understanding the estrous cycle of rats due to the variations of 
circulating estrogen during various parts of the cycle. Although not identical, the estrous 
cycle in rodents can serve as a useful tool to model the influence of the menstrual cycle in 
humans on blood pressure regulation. The estrous cycle in rats is separated into 4 phases 
compared to the 2 phases in humans. These cycles, in order, are proestrus, estrus, 
metestrus (diestrus I), and diestrus (diestrus II). A cycle is approximately 4 to 5 days in 
most rats, whereas the human menstrual cycle lasts around 28 to 30 days. Estradiol levels 
begin to increase in diestrus I, eventually leading to a peak in proestrus and going back to 
baseline around estrus. Progesterone also increases during diestrus I and II with a gradual 
decrease afterwards, following a second peak in proestrus (Lebron-Milad, 2012).  
Figure 7 is a comparison of the human menstrual cycle versus the rat estrous cycle 
(Lebron-Milad & Milad, 2012). The first peak of estrogen is related to the release of an 
ova, while the second peak is associated with the fertilization. The second peak would 










Figure 7. This figure compares the human menstrual cycle vs the rat estrous cycle. There 
are similar fluctuations of estrogen and progesterone presence in both rat and human 
species.  
 
Figure 8. This figure represents time in each stage of the rat estrous cycle. Estrus and 
Diestrus II being the longest, and Diestrus I and Proestrus being the shortest.  
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6. PVN in Blood Pressure Control 
The nervous system is broken down into the central nervous system, consisting of 
the brain and spinal cord, and the peripheral nervous system, consisting of peripheral 
nerves. The peripheral nervous system is further subdivided into the involuntary 
autonomic nervous system and the voluntary somatic nervous system. Our study will be 
focusing on the autonomic nervous system, more specifically the sympathetic division, 
which is commonly associated with the arousing “fight-or-flight” reflex. This autonomic 
nervous system communicates to the internal organs and glands about the external 
environment. The sympathetic nervous system is associated with pupil dilation, heart rate 
and blood pressure increase, stress response, thermoregulation, and regulation of blood 
flow to the muscles. Conversely, the parasympathetic nervous system (PNS) is associated 
with the “feed-and-breed” reflex. The parasympathetic nervous system exacts control on 
lacrimation and salivation, erectile function, increased digestive motility, and micturition 
is increased as well (Benarroch, 2020). The PNS also affects heart rate and blood 
pressure via the influence of the vagus nerve on the heart. There is little PNS input to the 
vasculature in general.  
Within the brain, there are multiple centers for coordination of autonomic activity. 
Many of these are in the hindbrain. Others are located within the midbrain areas, such as 
the hypothalamus. One hypothalamic area that has been consistently linked with blood 
pressure regulation is the paraventricular nucleus (PVN). As the name may suggest, it is a 
cluster of cells that lies along the border of the third ventricle. It is a multifunctional area 
of the brain. In terms of blood pressure regulation, it has two primary mechanisms. It is 
important in the production of vasopressin and oxytocin, which then move down 
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neurosecretory cells to be stored and released by the pituitary gland. The hypothalamus is 
linked accordingly to the pituitary gland and is important in the release of certain 
hormones and neuropeptides which can then impact blood pressure (Ferguson et al, 
2008).  
With a focus on neuroendocrine and neurotransmitter involvement, one study 
suggests that hypothalamic inflammation disrupts the central control of blood pressure, 
therefore suggesting future studies regarding hypothalamic sympathetic stimulation and 
blood pressure control (Khor & Cai, 2017). This central neural control on cardiovascular 
function has been a large focus in many studies. The brain regulates cardiovascular 
function by two primary mechanisms: feedforward regulation and feedback regulation. 
Baroreceptor, chemoreceptor, and other reflexes contribute to blood pressure control to 
overcome internal and environmental challenges (Dampney, 2016). Alongside these 
challenges, our bodies must fight to remain in a homeostatic state. Inability of our body 
to compensate can result in a complete loss of bodily control and decompensation can 
lead toward death and disability. In Dampney’s study, they studied renal sympathetic 
nerve activity (RSNA) as well as cardiac output in regard to hypothalamic regulation, 
whether it be in the supraoptic nucleus, paraventricular nucleus, or other regions. Below 
is a graph from Dampney’s study showing these complex autonomic linkages and how 
they can affect blood pressure and other important mechanisms (Dampney, 2016). 
Involvement of the sympathetic nervous system, differences with sex and sex 
hormones, and brain involvement in blood pressure are key topics in this study that will 
be looked into deeper to help understand our cardiovascular physiology and progression 
of disease. With the overwhelming statistics showing an increase in cardiovascular 
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disease, renal disease, and cerebrovascular disease, it remains important to develop an 
understanding of the mechanisms of blood pressure, as well as how we can begin to 
diagnose, treat, and prevent these diseases.    
A study on estrogen-beta receptor (ER-beta) and androgen receptor (AR) was 
done on neurosecretory and non-neurosecretory cells located within the PVN. They found 
that both AR and ER-beta sites were concentrated in regions of the PVN without 
neurosecretory cells. This shows that gonadal hormones have a direct influence on 
preautonomic effector neurons and an indirect influence on adrenocorticotropin-
regulating neurons of the PVN (Bingham, Williamson, & Viau, 2006). 
Another study looked into the RAAS and its involvement in the brain. They found 
that the PVN is the single most crucial aspect of autonomic control. The complex 
neurocircuitry between the RSNA, CSAR, and PVN showed a large involvement with 
sympathetic activity and therefore increases in blood pressure and heart rate. They also 
found that stimulation of the caudal ventrolateral medulla (CVLM) provoked hypotension 
and bradycardia by reducing sympathetic tone (Farag et al, 2017). 
An increase in sympathetic tone is commonly referred to as the “flight-or-fight” 
response being that it helps an individual avoid and escape danger by increasing blood 
flow to vital areas and shunting blood away from others. According to a prior study on 
PVN dysfunction, this region is a promising area of future medical research with its 
several linkages to chronic heart failure and hypertension and with pharmacological 
targeting of this area, we may be able to understand, prevent, and treat various 
pathological outcomes (Feetham, O'Brien, & Barrett-Jolley, 2018). Understanding the 
autonomic control exhibited by the PVN will thus, in turn, allow us to better understand 
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the mechanisms of blood pressure control. CSAR can be stimulated by the introduction of 
certain substances, such as bradykinin, into the pericardial sac by the left ventricle of the 
heart. From this, this study will look into the effects this has on the PVN activity, heart 
rate, and blood pressure. We will study the differences between male and female subjects. 
 
 
7. Evidence for PVN in CSAR 
In keeping with its multifunctional character, abnormal physiology of the PVN 
can have a wide array of effects from amenorrhea and diabetes mellitus to autism and 
hypertension (Qin, Li, & Tang, 2018). Previous studies have linked the PVN to the 
CSAR. For example, cardiac sympathetic afferent reflex (CSAR) stimulation results in 
activation of cells located in the PVN, which can be seen using immunohistochemistry. 
The end result of this stimulation is a rise in blood pressure (Carmichael, 2015). 
With understanding the CSAR, we must then link the PVN to this reflex, and 
therefore potentially link activity to the alterations in maintenance of blood pressure. 
Studies have shown that stimulation of a certain area of the heart causes a cardiac afferent 
impulse to the PVN (Coote, 1995). Bradykinin, a peptide inflammatory mediator, placed 
within the pericardium causes CSAR stimulation, which is transmitted to the PVN via 
neural afferents, which then results in a rise in blood pressure (Chen et al, 2015). A study 
at Nanjing Medical University in Nanjing, China found that the PVN is in the central 
pathway of CSAR reflex in rats. With rats being the subject in our own study, this study 
is of high relevance to our own. In this study, they used anesthetized Sprague-Dawley 
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rats and looked into renal sympathetic nerve activity (RSNA) and mean arterial pressure 
(MAP). The CSAR was evaluated by the response of the RSNA when bradykinin or 
capsaicin was applied to the epicardium, which showed an increase in RSNA and blood 
pressure. In conjunction with this evaluation, they saw that inhibition or lesion to the 
PVN with the same stimuli showed no response in blood pressure or RSNA, providing 
evidence that the PVN was involved in the CSAR (Zhong et al., 2008).  
Other work examined the contributions of the thalamus and PVN of the 
hypothalamus to the cardiac sympathetic afferent reflex. This study is a key link for our 
study and the PVN in the CSAR stimulus. The study found that while the thalamus is 
activated, it is not critical for autonomic regulation and adjustment in response to 
activation of the CSAR. Providing further evidence that the PVN is critically involved in 
this central pathway of the CSAR (Xu, Zheng, & Patel, 2013). They studied this by 
applying bradykinin or capsaicin on the epicardium of the left ventricle and then 
evaluating the activation of the PVN. They also found that application of lidocaine 
inhibited the CSAR response, helping them conclude that the PVN and CSAR was 
linked. 
With studies linking the PVN to the CSAR reflex, we can expect the same effect 
in our study. However, previous work was done in male rats. To our knowledge, the roles 
of the PVN in CSAR has not been studied in female rats. Upon our stimulation of the 
PVN, we can compare and contrast the PVN activity alongside the sympathetic activity in 
both the male and female rats. 
While many factors go into blood pressure regulation, this study will be focusing 
on the cardiac sympathetic afferent reflex (CSAR) alongside paraventricular nucleus 
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(PVN) activity and how that contributes to the management of blood pressure. 
Understanding this CSAR stimulus and how it activates the PVN can possibly lead us to 
a better understanding of blood pressure control. Thus, dysregulation of this region of the 
brain and/or CSAR can possibly be associated with other processes that also control 
blood pressure (Carillo et al, 2012). Figure 9 below is a flow chart showing autonomic 
control discussed in Carillo’s study.  
 
Figure 9. The intricate concept map above shows the central nervous system command 
over many important functions that relate to oxygen being supplied to the tissues that 
need it. 
 
8. cFos as a Neuronal Marker  
To map the functional anatomy, expression of the cFos protein is used as neuronal 
marker. The cFos protein is an early gene product expressed in response to neuronal 
activation. This protein is expressed in the nucleus of the activated cells, which, with a 
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second identifying antibody, we will be able to visualize using immunohistochemistry 
(IHC). The mapping of this cFos protein is a useful tool to determine where a large 
amount of brain activity is elicited during various stimuli (Hoffman et al, 1993). As it is 
an immediate early product of these changes, it is also rather short in duration. From this, 
for detection of cFos, we must preserve the protein before this time elapses (Dun et al, 
1995). With this technique to trace functional units of activated circuits and synaptic 
plasticity in the brain, we can further link areas of the brain that work in conjunction to a 
certain bodily mechanism or response (Murphy et al, 2004).  
Figure 10 is an example of cFos staining on a rat hippocampus with DAPI nuclear 
staining in immunohistochemistry (“c-FOS Antibody”, 2021). 
 
 
Figure 10. This is representation of immunohistochemistry staining of c-Fos 
proteins/DAPI in a section of brain from a rat hippocampus. DAPI is blue and represents 




9. Estrogen and Testosterone Receptors in the PVN 
Expanding on the idea of differences in sex and blood pressure control, we must 
explore more deeply into what makes males and females so different from an endocrine 
standpoint. When an individual is being carried in gestation, sex hormones are produced 
and affect the fetus. For males, testosterone is the main sex hormone that causes the 
formation of the testicles and penis. Later in life, testosterone causes the males to develop 
facial hair. For females, estrogen and progesterone are the sex hormones that give the 
female sex characteristics. In addition to the obvious characteristics, one study showed 
that sex differences caused a greater instance in angiotensin II induced hypertension, both 
in occurrence and severity. Importantly, they saw that these sex hormones had 
modulating interactions with the brain and other parts of the body aside from the 
reproductive system. One part of this study showed that non-ovariectomized mice had 
decreased pressor effects of angiotensin II, while ovariectomized mice had a higher effect 
on pressor action of angiotensin II (Xue, Johnson, & Hay, 2007). One site of action may 
be the PVN. As described earlier, a study found that estrogen-beta receptors and 
androgen receptors had direct linkages to preautonomic neural regulation.  
Another study worked on linking these sex hormones to autonomic control of 
blood pressure. From here, they worked in sympathetic nerve activity alongside sex 
hormones. They saw that sex differences in blood pressure regulation are likely to have 





10. Translational Research from Lab Rats to Humans 
Studies have been done throughout the years on many different animal subjects. 
This is due to many similarities of different mammals compared to humans, these being 
other primates, rodents, etc. In regard to many aspects of mammalian physiology, primal 
functions remain very similar. While numerical values may differ, the mechanisms are 
similar, and manipulation of these mechanisms will yield the same effects across many 
species. This has been shown to produce important medications such as heparin, insulin, 
glucosamines, etc. With respect to cardiovascular function, baroreflex control of blood 
pressure and other variables have been studied in humans, dogs, rats, and other mammals, 
with many of the same outcomes. Reflexes from the heart show great comparison across 
many mammalian species (Sleight, 2014). Accordingly, we can say that our study will 















STATEMENT OF RATIONALE 
The background information above shows that there is a strong relationship 
between the CSAR and the PVN. Studies have shown that stimulation of a certain area of 
the heart causes a cardiac afferent impulse to the PVN. Afterward, the effect of this 
stimulation is an increase of blood pressure. Data also shows that there is a considerable 
influence in sex on blood pressure and blood pressure control mechanisms. Alongside 







We hypothesize that there will be a significant difference between male and 










I. Determine if there are differences in CSAR-induced hemodynamic 
response in male and female rats.  
We will do this by examining blood pressure and heart rate recordings during the 
procedures, particularly during the bradykinin induced CSAR stimulus. Peak blood 
pressure and heart rate will be assessed in male and female rats as well as the duration of 
the response.   
 
II. Identify that PVN activity was activated by stimulation of the CSAR 
Slices of the subject’s brain will be placed on a slide for examination. From there, 
tests can take place to determine where activity occurred upon stimulation via CSAR. 
Expectations are that the subjects will have similar areas of stimulation. 
 
III. Identify differences between male and female PVN activity with 
stimulation of the CSAR  
Moving from Aim II, male and female subjects will be compared to determine if 










1. Animals  
For this study, we will be using both male and female Sprague-Dawley rats 
(Rattus norvegicus domestica). These rats will range in weight between 250 and 450 
grams. Weight-based calculations will be done to determine the proper amount of 
anesthetic and other drugs. They are housed in the same living space in separate cages, 
with 2 rats of the same sex are in the same cage. Sexes are separated to avoid mating, 
stress, and fights. All rats are on the same diet, with daily inspections to assure proper 
management of the cage environment. The housing of the rats has a 12-hour light cycle. 
Diet consists of a Teklad Global brand feed which consists of a 16% protein, 3.5% fat, 
and 5% fiber pellet that is placed in a feeding area and checked for proper feeding times 
and diet management. These rats come from either from the in-house breeding program 
or a breeding and distribution company, Invigo. There is a veterinarian with the animal 
resource center alongside many veterinarian technicians and primary investigators that 
ensure the health and wellness of each animal. We have also been given approval to 
conduct this study by the institutional animal care and use committee (IACUC) and we 
also follow protocols approved by the National Institute of Health (NIH) Guide for Care 






2. Surgical Interventions: Vascular Surgeries 
Rats were weighed and then placed into a chamber for anesthesia. Rats were 
anesthetized by inhalation of isoflurane 2.5-3% in Oxygen at 0.3 L/min. Once the animal 
is anesthetized, it will be moved to the preparation area, and hair will be removed in 
surgical areas. These areas will be scrubbed with 70% ethanol. Surgical technique will 
consist of multiple surgeries.  
The first procedure will consist of vascular surgery to create access to the femoral 
artery and vein. Forceps and blunt scissors will be used to gain access and reveal the 
femoral triangle. Blunt dissection will allow us to move away surrounding tissue without 
damaging nearby blood vessels. 2% Lidocaine will be periodically infiltrated into the 
area to dilate the vessels of interest to allow for easier catheter insertion, as well as 
providing local anesthesia. Blunt dissection also be used to isolate the femoral vein, 
artery, and nerve from each other. Surgical suture will be threaded around each vessel to 
allow for occlusion and ligation if need be. This surgical suture is placed proximally and 
distally from the site of insertion. Hemostats are used to provide traction to the vessel via 
these suture loops to ligate. Insertion of the arterial catheter will be accompanied by 
proximal stoppage of blood flow to prevent excess loss in blood volume. The P-50 tubing 
will be tapered at the end and a scalpel will be used to remove any burrs. Burrs are 
removed due to their shearing nature when inserted into the vessel. This shearing can 
hinder catheter insertion and possibly damage the vessel to the point where the vessel is 
compromised. Fine forceps and vessel scissors will be used to insert the P-50 catheter. 
The vessel scissors are used to make a small incision in the vessel that is big enough to 
allow easy insertion of the P-50 catheter. The arterial catheter will be advanced into the 
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abdominal aorta and used to monitor blood pressure and heart rate of the subject. Normal 
saline 0.9% can be administered through the arterial line to maintain intravascular 
volume. The venous catheter is inserted in the femoral vein in nearly the same manner as 
the arterial catheter. Proximal stoppage of blood flow is generally not needed as the 
venous pressures are far lower than the arterial pressure. The venous catheter will be used 
to switch the subject from isoflurane anesthesia to intravenous anesthesia using alpha 
chloralose (80 mg/kg) + urethane (800 mg/kg) anesthesia.  The latter anesthesia was 
chosen because it has been used in neural studies in the past because it has minimal 
depressant effects on neural pathways. To transition the animal, we first give 0.05 mL of 
urethane chloralose through the venous line. Each urethane chloralose administration is 
accompanied by a drop in blood pressure, therefore each dose is spaced accordingly to 
allow blood pressure recovery prior to giving the next dose. Urethane chloralose 
maximum dosing is dependent on weight. The maximum number of doses is 1/25th of the 
subject’s weight in grams. (Example: A 350-gram rat will receive a max of 14 doses 
0.5mL urethane chloralose. After 3 to 5 doses, inhaled isoflurane sedation is gradually 
lowered from 1.5% to 1%. After the 8th dose, the isoflurane should be nearing 0% and 
can be turned off. Pain assessment will be done periodically to ensure that the subject is 








Figure 11. The figure above shows the anatomy that will be visualized during the 
vascular surgeries (Lau et al., 2010). 
 
3. Surgical Interventions: Tracheal Surgeries 
Another surgery used will be the creation of a patent airway via tracheostomy. 
This establishes an airway to allow for mechanical ventilation when thoracic cavity entry 
is achieved or in case the subject becomes dyspneic or ceases to breathe. If breathing 
ceases before the insertion of the tracheostomy, a nasal bulb will be placed over the nose 
and ventilations will be provided until spontaneous breathing returns. The tracheostomy 
procedure is started by making an incision in the tracheal area using blunt scissors and 
forceps. Muscle and fat are dissected apart along the midline. It is important to remain at 
the subject’s midline to avoid large vessels and nerves that occupy the area. Dissecting 
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through the muscle, the cartilaginous rings of the trachea will be revealed. Using curved 
forceps, suture will be placed posterior of the trachea and used to secure the airway later 
and prevent fluid drainage into the stoma and occlusion of the airway. Fluid accumulation 
is common so tight securing of the tube is essential in preventing fluids from occluding 
the airway. Using fine scissors, the trachea will be cut, and a tube will be placed into the 
stoma. Once the tube is inserted, fogging of the inserted tube will be assessed to ensure 
patency, and the tube will be secured. This airway is needed due to loss of ventilatory 
status once the thoracic cavity is opened for pericardial catheter placement. A ventilator 
is used if ventilatory drive is lost beforehand, or once thoracic cavity opening has 
commenced. The ventilator is set to 65 breaths per minute and delivers a tidal volume of 
between 2.5 to 5 mL, which is adjusted to match the rat’s chest excursions. 
 
Figure 12. This figure demonstrates the anatomy involved with tracheostomy tube 
placement. As mentioned earlier, it is important to remain midline to avoid large arteries 
(Hyytinen et al., 1999). 
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4. Surgical Interventions: Pericardial Surgeries  
The final surgery will consist of entry into the thoracic cavity for placement of a catheter 
within the pericardial space alongside the left ventricle of the heart. This catheter will be 
used for bradykinin and saline delivery. It is important to switch the subject to a 
ventilator prior to thoracic cavity entry due to the loss of negative pressure driving 
ventilation when the chest is opened. Once on the ventilator, we use blunt scissors to 
open the left side of the subject’s chest alongside the 4th intercostal space. Blunt 
dissection will be used to avoid the cutting of surrounding large vessels. Layer after layer 
of muscle will be separated until entry is achieved. These muscles are, from superficial to 
deep: the serratus anterior muscle, external intercostal muscle, and internal intercostal 
muscle. From here, rib spreaders will be used to gain a better visual of the subject’s 
anatomy. After locating the thymus, which appears greyish and resides above the heart, it 
will be retracted to better visualize the pericardial membrane. A small hole will then be 
made in the pericardium by using fine forceps to prod the pericardium, thus making a 
small hole just big enough for catheter placement. The 90-degree P-10 tubing will be 
inserted along the left ventricle. The 90-degree P-10 tubing is made by heating the end of 
tubing about ½ to 1 inch away from the tip. The end of the tubing will soon become 
pliable and turn downward. Once it reaches a 90-degree angle, we stop the soldering gun 
and the tubing cools. The angle of the P-10 tubing enables us to deliver the bradykinin 
and saline vehicle to the left ventricle. A 30-gauge needle will be used to insert holes into 
the tubing from the 90-degree angle to the tip. Figure 13 illustrates the placement of the 
pericardial catheter. This allows for optimal distribution of the injected solution to be 
delivered to the left ventricle, optimizing CSAR response. Strong glue cyanoacrylic 
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adhesive (Vetbond 3M) will be applied to ensure placement. It is important to be 
conservative with the adhesive as it can damage the heart and occlude the pericardial line. 
After pericardial catheter placement, the chest incision will be sutured using 4-0 or 6-0 
silk suture and closed. The subject will then be taken off the ventilator and respiratory 
status will be evaluated. After being taken off the ventilator, the subject should be 
breathing on their own after 5-15 seconds. Chest rise will be assessed, and needle 
thoracostomy will be used to evacuate the chest and reinflate the lung if needed. This 
ends the surgical procedures on the subject and data will be acquired after a recovery 
period of approximately 60 minutes. At the end of the protocol, the subject will receive a 
lethal dose of urethane chloralose anesthesia and relevant tissues will be collected. Below 
is an image of the rat thoracic anatomy to help better visualize where thoracic entry will 
take place and how pericardial catheterization is performed (adapted from “Rat 
Dissections”, 2012). 
Figure 13. Above is an image of the rat anatomy used as a reference to guide surgeries 
and establish necessary landmarks and a schematic of a CSAR stimulus. 
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5. Blood Pressure and Heart Rate Recordings 
The vascular surgeries detailed above enable us to monitor the blood pressure and 
heart rate throughout the protocol. Blood pressure and heart rate recording will be 
evaluated from arterial line insertion to the administration of the lethal dose of anesthetic. 
Data is acquired by using a transducer to encode the blood pressure and heart rate in an 
electrical signal transmitted to the data acquisition system. This data acquisition system is 
Acknowledge; Biopac which monitors the pulsatile flow from the arterial line. This data 
is acquired at 100 Hz. Baseline blood pressure and heart rate will be determined prior to 
administration of any drugs. This is done by letting the subject recover for at least 60 
minutes after the closing of the thoracic cavity. It is important to have blood pressure 
measurements available at all times during the procedure. This is because administration 
of anesthetic at low blood pressure will cause cessation of breathing and then lead to 
cardiac arrest. It is also important because then we have an accurate way to determine 
changes in blood pressure and heart rate following saline and bradykinin administration.  
The 10 μg/kg/0.1mL bradykinin solution is made by weighing bradykinin on a 
sensitive scale and adding to 0.9% normal saline to the correct concentration. Saline is 
used as a vehicle injection into the pericardial space. This dose was chosen because 
previous work showed that it increased CSAR activity once delivered through the 
pericardial catheter and onto the left ventricle (Martin, 2020).  
Then, we can determine the total amount of change to blood pressure and heart 
rate at its peak, timed blood pressure and heart rate assessments, and its overall duration. 
Peak, as well as 2-minute intervals until responses cease, are assessed and recorded on an 
excel spreadsheet. The excel spreadsheet was also used to evaluate means and standard 
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deviations between each group. The data transferred to GraphPad for statistical analysis 
and graphing.  
Data is presented as mean +/- SEM. Comparisons between males and females 
were made by unpaired t-test or for timed data by repeated measure ANOVA with 
Student-Newman-Keuls test. Significance was deemed at P < 0.05.   
 
6. Tissue Collection and Brain Sectioning 
Before administration of the lethal dose of urethane chloralose, vaginal epithelium 
of female rats will be swabbed to determine estrous cycle stage. The vaginal swab will be 
placed under a microscope for viewing. As mentioned in an earlier section, the estrus 
stage tends to consist predominantly of cornified epithelial cells. This stage tends to have 
a duration of 36 hours. Diestrus I is characterized by a decrease in cornified epithelial 
cells with a large number of leukocytes. Diestrus II shows mainly leukocytes, with some 
nucleated epithelial cells appearing. Diestrus I and II lasts around 48 hours, with Diestrus 
I being around 6 to 10 hours. Proestrus is characterized by nucleated epithelial cells. This 
stage lasts 12 hours. 
Tissue collection is achieved after the lethal dose of anesthetic is administered. 
Immediately prior to this, Evan’s blue dye is placed in the pericardial space to ensure that 
the catheter was effectively placed. The subject’s heart will continue to beat very slowly 
compared to the normal heart rate following the lethal dose of anesthetic. Following is a 
procedure that allows us to fix the tissues we plan to collect. This procedure is done by 
entering the abdominal cavity and moving up through the diaphragm, avoiding the heart 
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and large vessels. After visualizing proper placement of the pericardial catheter, we then 
cut the superior and inferior vena cava at the right atrium and insert a needle into the left 
ventricle. 50 to 60 mL of cold 0.9% normal saline is pushed into the left ventricle to clear 
blood out of the vessels. Then, 50 to 60 mL of 4% cold PFA is administered into the left 
ventricle to allow for fixation of the tissues. Following this step, we can now harvest the 
brain. This is done by using large scissors to remove the head. The spinal canal then 
allows us to access the brain. Peeling back sections of skull using rongeurs, while 
avoiding taking damage to the cerebrum, we then are able to observe underneath the 
brain and cut cranial nerves attaching the brain to the base of the skull. The brain will 
then be removed and placed in 4% PFA for further fixation and after 24-48 hours, the 
brain is placed in a 20% sucrose solution as a cryoprotectant.  
Brain sectioning is completed by using a Cryostat. A bucket of dry ice crushed 
into a snow is also gathered to allow for a flash freezing of the brain. The brains are 
blocked with a scalpel or razorblade anteriorly and posteriorly of the region of interest. 
The brains are then secured to a pedestal with cryogel and placed into the dry ice snow, 
and later the cryostat for freezing. The cryostat is set between -12 to -20 degrees Celsius, 
adjusting as needed to provide the best available sections. The brains are set in the 
cryostat for at least 30 minutes before any sectioning can take place. This is to ensure the 
entire brain is uniformly the same temperature. The brains can be sectioned at 30 μm 
thickness each. 3 sections are placed on a single slide and spaced to allow a hydrophobic 
barrier to be drawn between sections. These sections are then placed into a slide box for 




7. Immunohistochemistry and Fluorescent Imaging 
Immunohistochemistry (IHC) was used to assess protein expression in the PVN. It 
involves multiple steps to ensure proper imaging. A hydrophobic barrier will be placed 
around each section using an ImmEdge pen. This step is crucial to avoid leakage of 
primary and secondary antibodies from one section to another. The first step involves 
antigen retrieval and requires an IHC citrate buffer to be heated until boiling, usually 5 
minutes. This citrate buffer will be added to the slides containing brain sections to allow 
for antigen retrieval. After the heated citrate buffer is carefully added to the sections, 
allowing for full coverage of the slide to avoid drying, the slides will be placed into the 
microwave and boiled for an additional 7 minutes. After 7 minutes in the microwave, the 
slides will be immediately placed into ice and rapidly cooled over an hour timespan. 
During this hour, additional resources can be retrieved to prepare for the next steps. After 
the hour of cooling, a phosphate buffer solution with added 1% Tween (PBS-T) will be 
used to wash the slides for 5 cycles of 5 minutes each. 
The next steps involve the placing of primary antibodies onto each section to 
target the protein of interest. We will be using primary antibodies specific for cFos 
protein, androgen receptors, and estrogen receptors. Each primary antibody has a 
designated desired concentration for IHC studies. For cFos primary antibody 
concentrations, we used Abcam cFos (#ab190289) antibodies made in rabbit, at various 
dilutions between 1/200 and 1/1000, diluted in a solution of 10% goat serum in PBS-T. 
For androgen receptor primary antibodies, we used Invitrogen androgen antibodies 
(#PA1-110) made in rabbit, at 1/20, 1/40, and 1/80 concentration diluted in a solution of 
10% goat serum in Aquablock or PBS-T. For estrogen receptor primary antibodies, we 
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used Invitrogen estrogen antibodies (#PA1-310B) made in rabbit, at 1/50, 1/100, and 
1/150 concentration diluted in a solution of 10% goat serum in Aquablock or PBS-T. If a 
large amount of non-specific binding is present, goat serum may be placed on the 
sections for 5-10 minutes to allow for binding to non-specific sites. After the primary 
antibodies are placed, the slides are then placed into a 4-degree Celsius refrigerator on an 
oscillating rack for 24 to 48 hours. It is important to handle with care to avoid spillage of 
antibodies from one section to another since that may contain differing concentrations. 
Also, a negative control with 10% goat serum in PBS-T should be added to compare to 
the other slides. Parafilm should be added to the slide box to avoid evaporation. 
After the 24 to 48 hours, the slides will be carefully washed with PBS-T and the 
secondary antibodies can be added. These secondary antibodies are fluorescent, therefore 
excess light should be avoided to prevent photobleaching. The Invitrogen anti-rabbit 
secondary antibody (#A32790) is added to each section at a concentration of 1/200 
diluted in a solution of 50/50 10% goat serum in Aquablock. The secondary antibody will 
be placed in a dark area at room temperature for 2 hours. After this period, the slides can 
once again be washed with PBS-T and a nuclear staining solution (DAPI) can be added 
and the slides coverslipped. Once again, light should be avoided to avoid photobleaching. 
The now coverslipped slides can be placed in the 4-degree Celsius refrigerator for around 
40 minutes to an hour to allow for DAPI nuclear staining. Once this time is up, the slides 
are ready to be viewed under the fluorescent microscope or can remain in the dark 
refrigerator until it can be viewed.  
The next step involves the fluorescent microscope, which starts with turning on 
the computer and starting the LAX microscope program. Placing the slide on the 
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microscope, the sections may be viewed, either through the microscope or through the 
computer. Objectives 5x, 10x, and 20x will be used to look at the sections. The secondary 
antibody fluoresces at 488 nm. DAPI fluoresces at 358 nm. Two images will be captured 
of each and overlayed to look at both secondary fluorescence and nuclear fluorescence. 
For each section, we will be looking at fluorescence in the PVN region. This assesses 
brain activity from the experimental interventions mentioned before and references will 



















1. Blood Pressure/Heart Rate Results 
After the surgeries are finished, we are able to deliver our medications to the 
epicardium of the left ventricle. First will be a 0.1 mL 0.9% normal saline bolus. This is 
done to assess the effect of injection into the pericardial space. Figure 14 is a screenshot 
of a saline epicardial response. Pericardial injection with saline vehicle had little 
consistent effect on either blood pressure or heart rate. 
Figure 14. Above is a response from saline administration to the epicardium through the 
pericardial catheter. The red arrow represents the time of administration. The top chart 
represents the blood pressure variation in real time. The bottom chart represents heart 
rate. There is little-to-no response from saline administration. The blue triangle represents 




 After the saline response has been completed and observed, a 0.1mL bolus of 
bradykinin 10μg/kg/0.1mL was administered through the pericardial catheter onto the 
epicardium. An example of this response is shown in Figure 15.  
Figure 15. Above is an example of the response from an administration of bradykinin to 
the epicardium through the pericardial catheter. The red arrow marks the time of 
administration.  
Both blood pressure and heart rate increase after bradykinin in administered. The 
peak responses in blood pressure and heart rate occurs around the second minute after 
administration. Blood pressure and heart rate then gradually decline toward baseline as 
the time progressed.  Blood pressure and heart rare responses from bradykinin 
administration can vary in individuals. The two graphs above showed the responses from 
a single individual. To understand this fully, we must look at an averaged comparison of 
all individuals over time throughout the surgery, as well as differences in bradykinin 
CSAR response in males versus females. Graphs below include this averaged response 
over time as well as bar graphs showing peak bradykinin CSAR response between the 
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sexes.  In males, the peak blood pressure averaged approximately 24 +/- 4 mmHg.  In 
contrast this response was somewhat attenuated in females, averaging 18 +/- 2 mmHg.  
The outcome was similar for heart rate responses.  The peak heart rate response in males 
averaged of 20 +/- 6 bpm whereas in females it was 12 +/- 4 bpm.  
 
Unpaired t-tests were conducted on data comparing male versus female rats.  Figure 16 
compared averaged peak blood pressure response to the CSAR stimulus. The two-tailed 
unpaired t-test resulted in a p-value of 0.2021. With our significance value deemed to be 
p < 0.05, this test was shown to be not significant.  Difference between means showed to 
be 6.20 +/- 4.329 mmHg with a 95% confidence interval of -4.393 to 16.79 mmHg.  
Figure 16 compared averaged peak heart rate response to the CSAR stimulus. The two-
 
Figure 16 This figure represents the average changes in blood pressure and heart rate caused 
by pericardial injection of  bradykinin in male and female rats. Males had an average BK 
induced blood pressure  response of 24 +/- 4 mmHg. Females had an average BK induced 
blood pressure response 18 +/- 2 mmHg. The right panel shows the difference in heart rate 
between males and females. Males had an average HR change of 20 +/- 6 bpm. Females had 
an average change of 12 +/- 4 bpm. 
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tailed unpaired t-test resulted in a p-value of 0.3065. With our significance value deemed 
to be p < 0.05, this test was shown to be not significant. Difference between means 
showed to be 8.200 +/- 7.338 bpm with a 95% confidence interval of -9.755 to 26.16 
bpm.  Thus, despite the apparent differences, neither the peak blood pressure or the peak 
heart rate responses were different between male and female rats.   
In order to assess more fully potential differences in blood pressure and heart 
rates responses between males and females, the time course of the responses in blood 
pressure and heart rate were analyzed.  Figure 17 shows the average blood pressure (left 
panel) and heart rate (right panel) changes from baseline over time for pericardial 
injection of saline or pericardial injection of bradykinin.  
 
Figure 17 This figure shows the average changes in blood pressure and heart over 
time following injection of either saline or bradykinin into the pericardial space of 
either male or female rats.  All error bars represent one SEM. Time of 0 minutes 
indicates peak response for each group with other data points being measured at 2-
minute increments.  
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All error bars represent one SEM.  Time of 0 minutes indicates peak response for each 
group with other data points being measured at 2-minute increments. Males, generally, 
had a larger change from baseline for both MAP and HR than females, with females also 
having a shorter duration in response.  We a conducted a 3-way ANOVA (factors: time, 
sex, treatment) on blood pressure and heart rate recordings over time in males vs females 
based on their treatment group. The 3-way ANOVA data for the heart rate recordings 
showed no overall significance between points. This may be attributed to the high amount 
of variance between individuals. The 3-way ANOVA data for the blood pressure 
recordings did detect significant effects of time, treatment and sex.  Post hoc analysis 
showed differences between pericardial BK and saline between 0 minutes and 8 minutes, 
with no significance from 10 minutes to 12 minutes after peak CSAR response in male 
rats.  In female rats significant differences between pericardial saline and bradykinin 
were detected at times 0 and 2 minutes.  However, differences were not significant at all 
other times.  Thus, female rats appeared to recover from the elevation in blood pressure 
caused by pericardial bradykinin more quickly than males.  Nevertheless, post hoc 
analysis failed to reveal any statistically significant differences between the bradykinin 
responses observed in male and female rats.  
We also assessed the overall response for blood pressure by calculating the area 
under the curve (AUC) for each animal and then expressed this as the average AUC for 
male and female responses to either pericardial saline or pericardial bradykinin.  These 
data are shown in figure 18.  We found that male bradykinin induced CSAR response had 
a total and net area under the curve of 180 +/- 57. We found that female bradykinin 
induced CSAR response had an average AUC of 81 +/- 28.  We were also able to 
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complete an ANOVA on the individual area under the curve values which indicated a 
difference amongst these groups.  Post hoc comparisons showed a significant difference 
between the BK and saline responses in male rats.  None of the other comparisons 
(female NS vs female BK; male BK vs female BK) achieved statistical significance.  
 
 
2. Immunohistochemistry Results 
We assessed potential male/female differences in PVN by immunohistochemistry.  
Within our immunohistochemistry trials, we looked into cFos. cFos binding indicates 
cFos presence, and since cFos is a short-intermediate acting protein in response to a 
stimulus, meaning there was a stimulus, our stimulus, causing presence. This binding was 
cross-referenced with DAPI nuclear staining.  
 
Figure 18  This figure shows the average area under the blood pressure curve obtained 
from individual responses to either pericardial injection of saline (NS) or bradykinin 
(BK)into male and female rats.   
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Controls are crucial to evaluation of immunohistochemical staining.  We used to 
types of controls as shown in figure 19.  The first was probing for DAPI (to indicate the 
nucleus) and cFos in the PVN region of rats that had received only pericardial saline 
injections (vehicle controls).  As described above these animals showed no systematic 
responses in blood pressure or heart rate.  The right panel of figure 19 shows an example.  
While DAPI staining is apparent, there is no cFos staining, suggesting that pericardial 
injection of saline did not activate cells in the PVN region.  The right panel of figure 19 
shows an antibody negative control, in which all reagents were added with the exception 
of the primary antibody.  Again, DAPI nuclear staining is readily apparent.  Although 
there is fluorescent green staining, this does not appear to be cellular in nature, and is 
clearly different from the following images showing cFos staining. 
  
 
Figure 19. The images above were two separate controls used. The right image 
shows a primary and secondary antibody treated brain section of a rat that received 
only a saline pericardial injection. The left image shows a 10% Goat Serum in 
PBS-T treated brain section of a rat that received a pericardial bradykinin injection. 
There is no cFos staining present 
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Figure 20 shows the outcome of the probing for cFos and DAPI in a male rat.  Left panel shows 
a lower power image to illustrate the punctate green fluorescent staining localized near the third 
ventricle.  The right panels show progressively increasing magnification of select cells to show 
merged DAPI and cFos staining indicating that the green fluorescent staining is consistent with 
nuclear cFos staining.  Figure 21 is a similar image captured from a female rat that received 
pericardial injection of bradykinin. These images again show that there is punctate green 
fluorescent staining in select cells in the region of the third ventricle.  The higher magnification 
image shows that the green fluorescent staining overlaps with the DAPI staining indicating that it 








Figure 20. Above is a captured image from the fluorescent microscope of a IHC trial 
looking at cFos/DAPI fluorescence. This image was taken with a 10x (left), 20x (top 
right), and 40x (bottom right), scale bars are present in each figure. You will notice 
staining in the early PVN region with DAPI nuclear staining overlapping, indicating 
that the staining is cellular. The black space to the center is the dorsal aspect of the 






Degree of immunostaining was completed on various 40x images collected for cFos 
staining. The Image J program from NIH was used to analyze the images collected. 
Within the PVN region, there was an average of 5.2 stained cells counted on each image 
collected, with a minimum of 3 and a maximum of 7 cells each image. Total area of 
staining averaged 4.486 square units per image, with a minimum area of 2.517 and a 
maximum area of 6.982. Average cell area staining was 0.8616 square units per cell, with 
a minimum of 0.567 and a maximum of 0.997 per cell.  
 
Although not a specific component of aim III, we wished to extend our findings 
by attempting to correlate cFos staining with the cellular localization of either estrogen or 
 
Figure 21.  Above is a captured image from the fluorescent microscope of an IHC 
trial looking at cFos/DAPI fluorescence in a female rat. This image was taken with a 
20x (left) and 40x (right). You will notice staining in the PVN region with DAPI 
nuclear staining overlapping, indicating cellular staining. 
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androgen receptors that are reported to influence preautonomic control in the PVN.  
Figure 22 shows two images from brain sections stained with antibody directed toward 
estrogen receptor beta.  The left panel shows an example of a trial with a 1/100 dilution 
of antibody.  Very little specific green fluorescent staining was observed.  The right panel 
shows another trial showing staining obtained with a primary antibody dilution of 1/50.  
Although there appears to be punctate staining, this is not conclusive as there seems to be 
very little overlap with the DAPI staining and very high background.  Thus, at present we 
cannot make any definitive conclusions regarding the estrogen receptor beta.   
 
 
 Androgen receptors, as mentioned earlier are thought to have direct linkages to 
preautonomic neural regulation. Using immunohistochemistry, we assessed the presence 
 
Figure 22. Above is fluorescent images of estrogen-beta receptor staining. We were 
unable to get specific staining in the PVN region. The image to the left was treated 
with a 1:100 dilution estrogen-beta receptor primaries and the right image was treated 




of androgen receptor sites within the PVN region in the hope of determining if there was 
overlap between cFos positive cells activated by pericardial BK and androgen receptors.  
Figure 22 shows the outcome of these trials.  Despite using very concentrated primary 
antibody solutions of 1/20, these trials were not very successful.  In the left panel of 
figure 23, it appears that there may be some punctate green fluorescent staining (arrow).  
However, this staining did not match up well with DAPI staining, leading us to question 
whether this cellular or was non-specific staining.  In addition, subsequent trials were not 
able to repeat this staining.  Unfortunately then, we cannot make any definitive 






Figure 23  This figure shows examples of two trials probing for androgen receptors using antibody 






Hypertension affects millions of Americans, which can lead on to many other 
problems over time. Stroke, myocardial infarction, and renal disease can all result from 
chronic hypertension. These debilitating diseases can greatly shorten an individual’s life 
as well as causing the loss of many years of productivity.  Dysfunction in blood pressure 
control mechanisms may contribute to these disease processes.  Thus, expanding our 
understanding of the mechanisms of blood pressure control is crucial as it can lead to the 
creation of more effective medications. With heart disease being the leading the cause of 
death, studies like this are vital in understanding how we can combat related disease. The 
mechanisms mentioned above could be a key in understanding how we can extend the 
lives of millions worldwide. Implications of research, such as our own, is understanding 
new facets of physiology, the ability to produce new medications which targets specific 
areas of this mechanism, and changes of current medications to avoid negative 
consequences and side effects.  
It is recognized that hypertension and associated diseases are different in females 
and males.  The aims of this study were to assess the differences in males and females in 
blood pressure and heart rate control mechanisms. We focused on a less well-understood 
control mechanism, the CSAR. While other studies have only looked into males and 
CSAR, we incorporated female subjects to evaluate the possibility of sex differences on 
this blood pressure control mechanism. Other studies examining responses in male rats 
showed that there was an increase in blood pressure and heart rate with CSAR 
stimulation. For example, a mean arterial pressure response increased upon capsaicin or 
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bradykinin application on filter paper directed to the left ventricle produced a blood 
pressure response of approximately 10 mmHg (Xu, Zheng, & Patel, 2013). Other work 
by McDermott in 1995 showed a mean arterial pressure increase with injection of 
bradykinin to the left ventricle by approximately 25 mmHg (McDermott et al., 1995). 
The approaches were different in the two studies by that the application of bradykinin 
was done via filter paper application in Zheng’s study, while McDermott injected 
bradykinin directly into the pericardial space which may account for some of the 
difference in the magnitude of the response. Our approach was closest to that of 
McDermott. In our male rats, we observed that injection of bradykinin into the pericardial 
space produced an increase in blood pressure of approximately 23 mmHg which is quite 
similar. Therefore, our findings are consistent with previous literature on the effects of 
bradykinin application to the left ventricle. 
In our study, we extended previous work by including female subjects, as well as 
having male subjects. Female subjects were observed to have a peak blood pressure 
response of approximately 18 mmHg. While there seemed to be a difference between the 
pericardial bradykinin-induced blood pressure response observed in males versus 
females, statistical analysis showed that this difference was not statistically significant. 
To examine this further, we plotted the time course in males versus females. This time 
course started at the peak and was monitored at 2-minute intervals. In these plots, the 
curve for male rats was consistently above that for female rat.  Thus, there appeared to be 
a difference in the blood pressure time course for males and females.  However, statistical 
analysis showed that this difference was not statistically significant. One approach to 
assessing differences over time is to calculate the area under the curve.  This approach 
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provides a more global estimate of differences between groups.  Indeed, as shown in 
figure 18, there was a considerably larger AUC for males compared to females.  Despite 
this apparent difference, unpaired t test analysis of did not detect a significant difference 
between these values.   
Similarly, we observed increases in heart rate that were comparable to previous 
studies. Unfortunately, the heart rate responses were more variable than the blood 
pressure responses.  The pattern in heart rate responses seen in males and females were 
similar to that of the blood pressure responses. In general, the heart rate responses were 
larger in males than females. This, however, showed no statistical significance.  
One of our goals was to compare blood pressure and heart rate responses in 
CSAR in male versus female rats. Although we were able to find qualitative differences, 
we were not able to find any quantitative statistically significant differences in males 
versus females.  There may be several reasons for this.  The small sample size no doubt 
contributed to a lower statistical power which in turn would make it difficult to detect 
statistical significance. Another factor could be the estrous cycle stage.  As detailed in the 
introduction, estrous stage affects estrogen levels in female rats and it thought that 
estrogen can affect blood pressure control mechanisms.  We did monitor what stage the 
female rats were in at the time of the surgical interventions.  However,  we did not stage 
the female rats throughout the estrous cycle to pick them in a specific stage.  This may 
have contributed to some variability in the female rats.  In addition, because low estrogen 
stages make up the bulk of the estrous cycle, most of the rats were in the low estrogen 
stages, and with estrogen having the cardiovascular effects mentioned earlier, this may 
have attenuated differences between the male and female rats.  It is possible that staging 
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the female rats in proestrous when estrogen levels are high would have further reduced 
the cardiovascular responses to pericardial injection of bradykinin and magnified the 
differences between male and female rats. 
Previous studies have found that the PVN plays a critical role in blood pressure 
regulation and in the CSAR.  In addition, differences in sex hormones do play a role in 
the progression of cardiovascular diseases and blood pressure control (Xu, Zheng, & 
Patel, 2013)(Chen et al., 2015) possibly with the PVN region (Xue, Johnson, & Hay, 
2013). These studies were paramount in guiding our own study and adjusting course 
when obstacles were faced. As with the blood pressure and heart rate responses, most 
previous studies examining the role of the PVN in the CSAR were conducted on male 
rats.  We wished to expand this to female rats.  We used cFos protein staining to evaluate 
activation within the PVN region of the hypothalamus. As previous reports have shown, 
stimulation of the CSAR via pericardial bradykinin caused an increase in neuronal 
activation in the PVN region as shown by increased cFos staining.  Thus, our findings in 
male rats were consistent with previous work on this topic.  We also observed increased 
cFos staining in the PVN region of female rats that received pericardial injection of 
bradykinin.  However, there appeared to be very minimal difference between the staining 
in males versus the staining in females in both aspects of total cell count, location, and 
intensity. This may mean that there is no difference in central affects in blood pressure 
control, but rather a difference in peripheral control. There are some limitations to our 
findings.  The issue of estrous stage has been addressed above and may also apply here.  
In addition, although we assessed the cellular staining as objectively as possible, this was 
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not done in a blinded fashion.  Thus, unconscious bias from counting may be present 
since we did not have a blind control of cellular staining.  
Our study was not able to get consistent data regarding estrogen and androgen 
staining within brain sections in the PVN region.  Thus, we were not able to correlate 
expression of androgen or estrogen receptors with cFos indicated neuronal activation. 
Previous work has demonstrated that estrogen and androgen receptors are expressed in 
the PVN region (Xue, Johnson, & Hay, 2013).  Therefore, we must interpret this to mean 
that our protocols were not working properly versus a lack of sex steroid expression in 
the PVN region.   This can be addressed in future studies where the estrogen and 
androgen IHC protocols are further expanded and refined and different primary 
antibodies are trialed. With this data not being very conclusive, future experiments are 
needed to help determine what this finding means.  
To summarize our overall findings, we found that while there appeared to be a 
difference between male and female subjects, the statistical analysis tools showed that 
there was no statistically significant difference. This may be contributed to by the 















With respect to our study and the findings within, future directions we may take 
can be quite similar or different to our current study. We may be able to introduce new 
surgical interventions, new antibody or antigen retrieval protocols, or incorporate 
different target receptors/areas of the brain.  
As for surgical interventions, we can incorporate other mechanisms of blood 
pressure regulation, such as the renin-angiotensin-aldosterone system, baroreceptor 
reflexes, and local vascular mechanisms. With this, we can develop new understandings 
of the mechanisms we have been studying and compare data from our studies to similar 
studies. 
With our study unable to get further evidence of binding at specific estrogen-beta 
receptor and androgen sites, we could expand and refine on the immunohistochemistry 
protocol to see if we can achieve greater success at specific binding sites.  
We can also introduce manipulation of sex steroids by giving or taking away 
estrogens or androgens. We could also manipulate estrogen or androgen receptors in the 
PVN by mRNA silencing. Also, assessment of the neurotransmitter phenotype of the 
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